#Medicine

#Med-Tech

#Innovations

#Technology

Biotechnology and Health, Medicine

MicroDrug

MicroDrug
Intelligent next-generation drug discovery platform

ABOUT THE PROJECT

The MicroDrug platform combines artificial intelligence-based analysis, synthetic biology and high-throughput automated processes to offer a scalable, precise and clinically validated approach to microbiome-based drug development, resulting in biosynthetic, multi-strain Next Generation Biotherapeutics that can be registered as drugs, supplements, foods or in other categories.

The Human Biome is setting a new standard in drug discovery based on the gut microbiota and is at the forefront of a new wave of biological innovation and “bio-mimetic” medicine.

WHAT NEEDS DOES THE INNOVATION ADDRESS?

The MicroDrug platform has the potential to revolutionize many therapies, especially in priority areas such as antibiotic-resistant bacterial infections, autoimmune diseases, neurological conditions, mental health, cancer, as well as other areas such as promoting longevity and healthy aging.

COMPETITIVE ADVANTAGES

The MicroDrug platform sets a new standard in microbiome drug discovery, offering full restoration of the complex gut ecosystem without donor involvement. In addition, unlike limited therapies containing few strains, multi-strain biotherapeutics more accurately reflect the natural human microbiome and provide higher clinical efficacy. Through the use of artificial intelligence, synthetic biology and automation, we can discover drugs tailored to various therapeutic indications in which the gut microbiota plays a key role.

Learn more!

MicroDrug

Human Biome Institute S.A.; Jarosław Biliński, Grzegorz Basak, Grzegorz Stefański, Tomasz Kostuch

SIMILAR INNOVATIONS

LUU positioning pacifier

The pacifier that is changing the future of baby’s health

Is something missing?

Submit your innovation!

Is something missing?

Submit your innovation!